Search

everythinglearnresearchcommunity

for

Search:↓

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Skin issues can signal substance use, helping early detection and treatment.

A cat had a rare severe reaction to fenbendazole, but recovered with treatment.

Testosterone may slow down wound healing and increase inflammation.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Melanin and melanocytes contribute to the brown pigmentation in stasis dermatitis.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Skin ulcers from interferon may not depend on the amount given.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Chronic kidney disease can cause skin issues that need early recognition and combined treatment for better outcomes.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.